Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score

Objective We evaluated survival outcomes of partial nephrectomy (PN) and radical nephrectomy (RN) for clinical T2 renal masses (cT2RM) controlling for R.E.N.A.L. nephrometry score. Patients and Methods A two‐centre study comprised of 202 patients with cT2RM who underwent RN (122) or PN (80) between...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2014-11, Vol.114 (5), p.708-718
Hauptverfasser:	Kopp, Ryan P., Mehrazin, Reza, Palazzi, Kerrin L., Liss, Michael A., Jabaji, Ramzi, Mirheydar, Hossein S., Lee, Hak J., Patel, Nishant, Elkhoury, Fuad, Patterson, Anthony L., Derweesh, Ithaar H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Biological and medical sciences carcinoma Cohort Studies Disease-Free Survival Female Humans Kaplan-Meier Estimate Kidney Neoplasms - pathology Kidney Neoplasms - surgery Kidneys Male Medical sciences Middle Aged Multiple tumors. Solid tumors. Tumors in childhood (general aspects) Neoplasm Staging nephrectomy Nephrectomy - methods Nephrology. Urinary tract diseases Ovarian cancer progression‐free survival R.E.N.A.L. nephrometry renal cell Stage 2 Survival Rate Treatment Outcome Tumors Tumors of the urinary system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective We evaluated survival outcomes of partial nephrectomy (PN) and radical nephrectomy (RN) for clinical T2 renal masses (cT2RM) controlling for R.E.N.A.L. nephrometry score. Patients and Methods A two‐centre study comprised of 202 patients with cT2RM who underwent RN (122) or PN (80) between July 2002 and June 2012 (median follow‐up 41.5 months). Kaplan−Meier analysis compared overall survival (OS), cancer‐specific survival (CSS) and progression‐free survival (PFS) among the entire cohort and within categories of R.E.N.A.L. nephrometry score of ≥10 and
ISSN:	1464-4096 1464-410X
DOI:	10.1111/bju.12580